Natural Course of Adolescent Major Depressive Disorder: I. Continuity into Young Adulthood
Overview
Authors
Affiliations
Objective: To examine the course of adolescent major depressive disorder (MDD) by comparing rates of mood and non-mood disorders between age 19 and 24 years in participants with a history of adolescent MDD versus participants with adolescent adjustment disorder with depressed mood, nonaffective disorder, and no disorder.
Method: Participants from a large community sample who had been interviewed twice during adolescence completed a third interview assessing Axis I psychopathology and antisocial and borderline personality disorders after their 24th birthday: 261 participants with MDD, 73 with adjustment disorder, 133 with nonaffective disorder, and 272 with no disorder through age 18.
Results: MDD in young adulthood was significantly more common in the adolescent MDD group than the nonaffective and no disorder groups (average annual rate of MDD = 9.0%, 5.6%, and 3.7%, respectively). Adolescents with MDD also had a high rate of nonaffective disorders in young adulthood (annual nonaffective disorder rate = 6.6%) but did not differ from adolescents with nonaffective disorder (7.2%). Prevalence rates of dysthymia and bipolar disorder were low (< 1%). Adolescents with adjustment disorder exhibited similar rates of MDD and nonaffective disorders in young adulthood as adolescents with MDD.
Conclusions: This study documents the significant continuity of MDD from adolescence to young adulthood. Public health implications of the findings are discussed.
The Impact of a Creativity Camp Intervention on Depression and Well-Being in Adolescents.
Cullen K, DiMaggio-Potter M, Klimes-Dougan B, Bernstein G, Koutstaal W, Reigstad K Child Psychiatry Hum Dev. 2024; .
PMID: 39412694 DOI: 10.1007/s10578-024-01766-3.
Common mental disorders among adolescents in an urban area of Delhi.
Ahmad A, Salve H, Nongkynrih B, Sagar R, Krishnan A Indian J Psychiatry. 2024; 66(4):347-351.
PMID: 38778841 PMC: 11107925. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_728_22.
Schwartz J, Roske C, Liu Q, Tobe R, Ely B, Gabbay V J Child Adolesc Psychopharmacol. 2024; 34(5):233-240.
PMID: 38669109 PMC: 11322627. DOI: 10.1089/cap.2023.0091.
Shu Y, Ao N, Wen X, Cui Z, Qu D, Chen R Eur Psychiatry. 2024; 67(1):e28.
PMID: 38425212 PMC: 10988157. DOI: 10.1192/j.eurpsy.2024.18.
Mishu M, Tindall L, Kerrigan P, Gega L PLoS One. 2023; 18(10):e0290653.
PMID: 37878658 PMC: 10599551. DOI: 10.1371/journal.pone.0290653.